Uni-Bio Science Group Dividends and Buybacks
Dividend criteria checks 0/6
Uni-Bio Science Group does not have a record of paying a dividend.
Key information
n/a
Dividend yield
1.4%
Buyback Yield
Total Shareholder Yield | 1.4% |
Future Dividend Yield | n/a |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend and buyback updates
Recent updates
Is Uni-Bio Science Group (HKG:690) Using Too Much Debt?
Dec 11Uni-Bio Science Group Limited (HKG:690) Surges 35% Yet Its Low P/E Is No Reason For Excitement
Sep 13Earnings Working Against Uni-Bio Science Group Limited's (HKG:690) Share Price Following 26% Dive
Jul 29Earnings Working Against Uni-Bio Science Group Limited's (HKG:690) Share Price Following 27% Dive
May 27Is Uni-Bio Science Group (HKG:690) Using Too Much Debt?
Apr 24Uni-Bio Science Group Limited (HKG:690) Held Back By Insufficient Growth Even After Shares Climb 28%
Jan 22Uni-Bio Science Group Limited's (HKG:690) Low P/S No Reason For Excitement
Oct 24Robust Earnings May Not Tell The Whole Story For Uni-Bio Science Group (HKG:690)
Apr 30We're Interested To See How Uni-Bio Science Group (HKG:690) Uses Its Cash Hoard To Grow
Nov 22Estimating The Fair Value Of Uni-Bio Science Group Limited (HKG:690)
Jan 05Companies Like Uni-Bio Science Group (HKG:690) Can Afford To Invest In Growth
Mar 01Uni-Bio Science Group (HKG:690) Share Prices Have Dropped 26% In The Last Five Years
Jan 05We're Interested To See How Uni-Bio Science Group (HKG:690) Uses Its Cash Hoard To Grow
Nov 23Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 690's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 690's dividend payments have been increasing.
Dividend Yield vs Market
Uni-Bio Science Group Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (690) | n/a |
Market Bottom 25% (HK) | 3.2% |
Market Top 25% (HK) | 8.1% |
Industry Average (Biotechs) | 1.1% |
Analyst forecast (690) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate 690's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 690's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate 690's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 690 has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/20 20:56 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Uni-Bio Science Group Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|